NLRP3 and early-onset autosomal dominant Alzheimer disease: For this reason, small molecules that can modulate autophagy and the NLRP3 inflammasome have been proposed as treatments for neurodegenerative diseases such as Alzheimer’s disease (Jha et al., 2023).